Table 2

Characteristics of those who prematurely stopped study regimen

Group variableTotalLow
(<6.1%)
Moderate
(6.1%–17.0%)
High
(>17.0%)
Sample, N1119404346369
Randomised to active treatment, N (%)531 (47.5)204 (50.5)151 (43.6)176 (47.7)
Age, years51.2±8.345.9±6.454.1±7.054.2±8.5
Male sex, N (%)626 (55.9)188 (46.5)243 (70.2)195 (52.9)
Current smoker, N (%)321 (28.7)58 (14.4)143 (41.3)120 (32.5)
SBP, mmHg159.1±18.1147.6±12.9157.0±11.9173.7±17.7
DBP, mmHg102.9±6.8100.0±4.0100.6±4.2108.1±8.2
Total cholesterol, mmol/L6.0±1.15.5±0.96.0±0.96.4±1.3
BMI, kg/m2 26.7±4.126.7±4.026.6±3.926.8±4.5
Reason for stopping
 Clinic, N (%)204 (18.2) 74 (18.3) 75 (21.7) 55 (14.9)
 Local doctor, N (%)287 (25.7) 98 (24.3) 87 (25.1) 102 (27.6)
 Participants, N (%)548 (49.0)204 (50.5)162 (46.8)182 (49.3)
 Not known, N (%)80 (7.2)28 (6.9)22 (6.4)30 (8.1)
  • Bold values: P<0.05 based on the distribution of baseline characteristics by treatment assignment.

  • BMI, body mass index; CVD, cardiovascular disease; DBP, diastolic blood pressure; SBP, systolic blood pressure.